Concepedia

Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention

George Dangas, Jonathan D. Marmur, Joshua De Leon, Raghuraman Vidhun, Dmitriy N. Feldman, Michael Y. Stoynov, Juan J. Badimón, John A. Ambrose

American Heart Journal · 1999 · 21 citations · 27 references

DOI

Concepts

References

27

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

The EPIC Investigators · New England Journal of Medicine · 1994 · 2.6K citations · Full text

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).

Thomas J. Ryan, David P. Faxon, R M Gunnar et al. · Circulation · 1988 · 2.1K citations · Full text

, , +8

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

The EPILOG Investigators · New England Journal of Medicine · 1997 · 1.9K citations · Full text

Unstable angina. A classification.

Eugene Braunwald · Circulation · 1989 · 1.4K citations · Full text

, , +5

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study

The Lancet · 1997 · 1.3K citations · Full text

, , +10